Henri Ramuz

1.3k total citations
26 papers, 1.0k citations indexed

About

Henri Ramuz is a scholar working on Organic Chemistry, Physiology and Molecular Biology. According to data from OpenAlex, Henri Ramuz has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Physiology and 7 papers in Molecular Biology. Recurrent topics in Henri Ramuz's work include Nitric Oxide and Endothelin Effects (10 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Receptor Mechanisms and Signaling (4 papers). Henri Ramuz is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Receptor Mechanisms and Signaling (4 papers). Henri Ramuz collaborates with scholars based in Switzerland, Japan and United States. Henri Ramuz's co-authors include Volker Breu, Martine Clozel, Werner Neidhart, Kaspar F. Burri, Georges Hirth, Walter Fischli, Marcel Müller, Gillian A. Gray, Jean‐Marie Cassal and Sébastiên Roux and has published in prestigious journals such as Nature, FEBS Letters and Journal of Medicinal Chemistry.

In The Last Decade

Henri Ramuz

26 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henri Ramuz Switzerland 14 583 346 306 206 124 26 1.0k
Kaspar F. Burri Switzerland 10 825 1.4× 493 1.4× 346 1.1× 249 1.2× 171 1.4× 14 1.3k
Jean‐Marie Cassal Switzerland 9 773 1.3× 457 1.3× 366 1.2× 226 1.1× 171 1.4× 11 1.2k
Georges Hirth Switzerland 11 849 1.5× 555 1.6× 586 1.9× 252 1.2× 201 1.6× 17 1.5k
Angelo J. Trapani United States 23 448 0.8× 661 1.9× 525 1.7× 139 0.7× 240 1.9× 74 1.6k
Fumihiko Ikemoto Japan 19 646 1.1× 680 2.0× 425 1.4× 113 0.5× 18 0.1× 84 1.2k
Kathryn A. Lysko United States 8 244 0.4× 310 0.9× 343 1.1× 92 0.4× 57 0.5× 8 889
Ellen G. McMahon United States 23 425 0.7× 789 2.3× 781 2.6× 238 1.2× 160 1.3× 45 2.1k
Brian D. Dayton United States 22 463 0.8× 211 0.6× 650 2.1× 107 0.5× 244 2.0× 38 1.5k
Stephen J. Haleen United States 18 377 0.6× 294 0.8× 371 1.2× 138 0.7× 121 1.0× 31 822
Yumiko Shibouta Japan 20 276 0.5× 637 1.8× 452 1.5× 70 0.3× 207 1.7× 41 1.3k

Countries citing papers authored by Henri Ramuz

Since Specialization
Citations

This map shows the geographic impact of Henri Ramuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Ramuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Ramuz more than expected).

Fields of papers citing papers by Henri Ramuz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Ramuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Ramuz. The network helps show where Henri Ramuz may publish in the future.

Co-authorship network of co-authors of Henri Ramuz

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Ramuz. A scholar is included among the top collaborators of Henri Ramuz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Ramuz. Henri Ramuz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bolli, Martin H., Corinna Grisostomi, Christoph Boss, et al.. (2004). Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists. Journal of Medicinal Chemistry. 47(11). 2776–2795. 59 indexed citations
2.
Ramuz, Henri, Volker Breu, Patrick Hess, et al.. (1999). Pharmacology of Tezosentan, New Endothelin Receptor Antagonist Designed for Parenteral Use. Journal of Pharmacology and Experimental Therapeutics. 290(2). 840–846. 118 indexed citations
3.
Roux, Sébastiên, Volker Breu, Thomas Giller, et al.. (1997). Ro 61–1790, a New Hydrosoluble Endothelin Antagonist: General Pharmacology and Effects on Experimental Cerebral Vasospasm. Journal of Pharmacology and Experimental Therapeutics. 283(3). 1110–1118. 86 indexed citations
4.
Neidhart, Werner, Volker Breu, Kaspar F. Burri, et al.. (1997). Discovery of Ro 48-5695: A potent mixed endothelin receptor antagonist optimized from bosentan. Bioorganic & Medicinal Chemistry Letters. 7(17). 2223–2228. 26 indexed citations
5.
Breu, Volker, Martine Clozel, Kaspar F. Burri, et al.. (1996). In vitro characterisation of Ro 46‐8443, the first non‐peptide antagonist selective for the endothelin ETB receptor. FEBS Letters. 383(1-2). 37–41. 31 indexed citations
6.
7.
Eliason, James F., Ryusuke Sawada, Toshiyuki Tsukaguchi, et al.. (1995). The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivo. European Journal of Cancer. 31(13-14). 2354–2361. 3 indexed citations
8.
Eliason, James F., et al.. (1995). Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro. Biochemical Pharmacology. 50(2). 187–196. 13 indexed citations
9.
Breu, Volker, Clemens Broger, Chikara Miyamoto, et al.. (1995). Separable Binding Sites for the Natural Agonist Endothelin-1 and the Non-Peptide Antagonist Bosentan on Human Endothelin-A Receptors. European Journal of Biochemistry. 231(1). 266–270. 39 indexed citations
10.
Clozel, Martine, Volker Breu, Kaspar F. Burri, et al.. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 365(6448). 759–761. 426 indexed citations
11.
Eliason, James F., Henri Ramuz, & Franz Kaufmann. (1990). Human multi‐drug‐resistant cancer cells exhibit a high degree of selectivity for stereoisomers of verapamil and quinidine. International Journal of Cancer. 46(1). 113–117. 26 indexed citations
12.
Williams, Harold L., et al.. (1990). Simultaneous determination of chloroquine and selected calcium(II) channel blockers by high-performance liquid chromatography. Analytica Chimica Acta. 228. 155–157. 8 indexed citations
13.
Ramuz, Henri, W. Schmütz, & Rolf Huber. (1989). Ro 11–2933, a potential drug in the treatment of cancer and malaria: synthesis and physicochemical properties; potential metabolites. European Journal of Medicinal Chemistry. 24(5). 493–496. 5 indexed citations
14.
Märki, Hans Peter, Yvo Crameri, Henri Ramuz, et al.. (1988). Optically Pure Isoproterenol Analogues With Side Chains Containing an Amide Bond: Synthesis and biological properties. Helvetica Chimica Acta. 71(2). 320–336. 14 indexed citations
15.
Hengartner, Urs, Jean-Claude Müller, & Henri Ramuz. (1983). Synthesis of 2‐Oxo‐2H‐[1,2,4]oxadiazolo‐[2,3‐c]pyrimidine‐5‐carbamates. Helvetica Chimica Acta. 66(2). 669–672. 1 indexed citations
16.
Ramuz, Henri. (1982). Tiapamil, Ro 11-1781, a Ca<sup>++</sup> Antagonist. Cardiology. 69(1). 26–30. 2 indexed citations
17.
18.
Tilley, Jefferson, et al.. (1980). Antihypertensive (2-aminoethyl)thiourea derivatives. 2. Journal of Medicinal Chemistry. 23(12). 1438–1439. 7 indexed citations
19.
Ramuz, Henri. (1978). A new Ca++ antagonist, Ro 11-1781, and its metabolites. Synthesis and physicochemical properties.. PubMed. 28(11). 2048–51. 11 indexed citations
20.
Ramuz, Henri. (1975). Synthèse et configuration absolue des énantiomères du Vér apamil. Helvetica Chimica Acta. 58(7). 2050–2060. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaspar F. Burri Breakdown of academic impact, for papers by Jean‐Marie Cassal Breakdown of academic impact, for papers by Georges Hirth Breakdown of academic impact, for papers by Angelo J. Trapani Breakdown of academic impact, for papers by Fumihiko Ikemoto Breakdown of academic impact, for papers by Kathryn A. Lysko Breakdown of academic impact, for papers by Ellen G. McMahon Breakdown of academic impact, for papers by Brian D. Dayton Breakdown of academic impact, for papers by Stephen J. Haleen Breakdown of academic impact, for papers by Yumiko Shibouta
Rankless by CCL
2026